Emerging evidence highlights the critical interplay between the NRF2 and NOTCH signaling pathways in lung cancer, where they also cooperate to reprogram metabolism in support of tumor growth, redox homeostasis, and therapy resistance [169,170,171]. Here, NFE2L2 is linked to neoplasm.